Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation.

TitlePhosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation.
Publication TypeJournal Article
Year of Publication2011
AuthorsLinares JF, Amanchy R, Greis K, Diaz-Meco MT, Moscat J
JournalMol Cell Biol
Volume31
Issue1
Pagination105-17
Date Published2011 Jan
ISSN1098-5549
KeywordsAmino Acid Sequence, Animals, Binding Sites, CDC2 Protein Kinase, Cell Line, Cell Line, Tumor, Cell Proliferation, Cell Transformation, Neoplastic, Cells, Cultured, Cyclin B1, Genes, ras, Humans, Male, Mice, Mice, Knockout, Mice, Nude, Mitosis, Molecular Sequence Data, Mutant Proteins, Phosphoproteins, Phosphorylation, Recombinant Proteins, Sequence Homology, Amino Acid, Signal Transduction, Tandem Mass Spectrometry, Transcription Factor TFIIH, Transcription Factors, Transcription Factors, TFII, Transfection
Abstract

The protein scaffold and signaling regulator p62 is important in critical cellular functions, including bone homeostasis, obesity, and cancer, because of its interactions with various signaling intermediaries. p62 is overexpressed in human cancers and is induced during cell transformation. Its genetic ablation inhibits lung tumorigenesis in vivo and cell proliferation in culture by regulating the TRAF6/NF-κB signaling cascade to control reactive oxygen species (ROS) production and apoptosis. Here we show that cdk1 phosphorylates p62 in vitro and in vivo at T269 and S272, which is necessary for the maintenance of appropriate cyclin B1 levels and the levels of cdk1 activity necessary to allow cells to properly enter and exit mitosis. The lack of cdk1-mediated phosphorylation of p62 leads to a faster exit from mitosis, which translates into enhanced cell proliferation and tumorigenesis in response to Ras-induced transformation. Therefore, p62 emerges as a node for the control of not only cell survival but also cell transit through mitosis.

DOI10.1128/MCB.00620-10
Alternate JournalMol Cell Biol
PubMed ID20974803
Grant ListR01AI072581 / AI / NIAID NIH HHS / United States
R01DK088107 / DK / NIDDK NIH HHS / United States
R01CA134530 / CA / NCI NIH HHS / United States
R01CA132847 / CA / NCI NIH HHS / United States
Related Faculty: 
Jorge Moscat, Ph.D. Juan Francisco Linares Rodriguez, Ph.D. Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700